Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disease modification in Parkinson's disease.

The Lancet. Neurology - 1 Jun 2004

Schapira Anthony H V

Abstract excerpt

Several separate gene mutations have now been identified in familial Parkinson's disease and important environmental influences modulating risk for the idiopathic form of the disease have also been recognised. These insights have provided important clues in the development of disease modifying therapies. Some compounds have already been shown to potentially delay disease progression in early clinical trials. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Environmental Exposure
Share to Free Radical Scavengers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Nerve Tissue Proteins

Share to Neuroprotective Agents

Share to Oxidative Stress

Share to Parkinson Disease

Share to Synucleins

Source

Identifiers

PMID: 15157851
DOI: 10.1016/S1474-4422(04)00769-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disease modification in Parkinson's disease.PMID 15157851Read ↗

Challenges to the development of disease-modifying therapies in Parkinson's disease.Semantic proximity Read ↗

Precision medicine for disease modification in Parkinson diseaseSemantic proximity Read ↗

Gene-environment interactions in Parkinson's disease.Semantic proximity Read ↗

Gene-environment interactions in Parkinson's disease and other forms of parkinsonism.Semantic proximity Read ↗

A Review of Genetic and Gene Therapy for Parkinson’s DiseaseSemantic proximity Read ↗

Genetic and environmental factors in the pathogenesis of Parkinson's disease.Semantic proximity Read ↗

Mechanisms of Gene-Environment Interactions in Parkinson's Disease.Semantic proximity Read ↗

Linking environmental risk factors with epigenetic mechanisms in Parkinson’s diseaseSemantic proximity Read ↗

Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease.Semantic proximity Read ↗

Nutrigenomics in Parkinson's disease: diversity of modulatory actions of polyphenols on epigenetic effects induced by toxins.Semantic proximity Read ↗

Effect Modification between Genes and Environment and Parkinson's Disease RiskSemantic proximity Read ↗

Promising disease-modifying therapies for Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.